South Korea · Delayed Price · Currency is KRW Apures Company Description
Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea.
It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs.
The company provides Porcine Primary Cell for in vitro test; and heterogeneous organ technology, a technology that develops and transplants animal tissues and organs to replace human tissues and organs.
It also manufactures and supplies Bio Membrane under the FCM brand, which is a research skin applicable to in vitro tests; and provides CRO services.
The company was formerly known as MediKinetics Co., Ltd. and changed its name to Apures Co., Ltd. in 2019.
Apures Co., Ltd. was founded in 2001 and is headquartered in Pyeongtaek-si, South Korea.
| Country | South Korea |
| Founded | 2001 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Choi Sundeok |
Contact Details
Address: 44, Hansan-gil Pyeongtaek-si, 17792 South Korea | |
| Phone | 82 3 1684 1508 |
| Website | apures.com |
Stock Details
| Ticker Symbol | 149300 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Choi Sundeok | Chief Executive Officer |